← Insider buys
XLRN

Acceleron Pharma Inc

Director Karen L. Smith sold $1.7M of Acceleron Pharma Inc

Sold$1,663,156
$140.19Price
11,864Shares
−88%Stake

What XLRN did after the filing

Prices for XLRN after this filing aren't in yet.

Traded Mon, Apr 5. Filed Mon, Apr 5, 4:17 PM ET, after the close. Not investment advice.